Amid new approvals last year, drugmakers also suffered R&D setbacks, cut research staff, rejigged their operations and refocused their pipelines.

French pharma Onxeo is teaming up with CRO Clinigen to bring blood cancer med belinostat to European patients in dire need through a managed access program.

After raising $31 million just last year, California-based clinical research company Science 37 has now served up a Series C round worth $29 million.

An expert panel has released new guidelines for modern clinical trials, examining the importance of utilizing telehealth technologies in clinical studies.

Celgene has reached its first licensing agreement in the Asia-Pacific region with Antengene, and CRO Tigermed will help with clinical studies.

U.K.-based CRO Chiltern has put itself up for sale as it continues the bullish M&A run for contract research groups that has seen a host of deals, JVs and…

China's FDA and Supreme Court, in a seemingly synchronized move, are proposing new actions against forging clinical trial data, and criminal charges are…

Texas-based Moleculin Biotech penned a deal with Theradex Systems to help it run early-stage trials for its candidate annamycin in acute myeloid leukemia.

Accelovance has launched a program focused on advancing early-phase oncology R&D efforts, which the company says haven’t received enough support from the…